-
Can the New Minoxidil Foam Revolutionize Hair Loss Treatment in China?
Hair loss affects a significant number of people in China, with over 250 million individuals experiencing some form of alopecia.
2024-01-12 15:23 -
Tire Wear and Aging Accelerate Neurodegeneration in Alzheimer's and Parkinson's Models, Study Finds
Leibniz Research Institute for Environmental Medicine in Düsseldorf, Germany, has revealed that tire wear, along with age and temperature, can hasten...
2024-01-11 17:52 -
FDA Proposes Ban on Brominated Vegetable Oil Due to Health Risks
The Food and Drug Administration (FDA) has recently proposed a ban on the use of brominated vegetable oil (BVO), a food ingredient commonly found in c...
2024-01-11 17:50 -
Controversy Surrounding Aspartame: Is It Safe or a Possible Cause of Cancer?
Aspartame, the artificial sweetener commonly found in diet soda and various food products, has recently come under scrutiny due to conflicting assessm...
2024-01-11 17:45 -
AiolosBio: The Middleman with an Eye for Opportunity in the Pharmaceutical Industry?
On January 9, pharmaceutical giant GlaxoSmithKline (GSK) announced its acquisition agreement with AiolosBio, a move aimed at strengthening its portfol...
2024-01-10 17:46 -
Is Johnson & Johnson's Acquisition of Ambrx a Game-Changer in the ADC Biotech Industry?
In an exciting development on January 8, 2024, Johnson & Johnson announced its acquisition of Ambrx, a groundbreaking biotech company, for a total dea...
2024-01-10 17:34 -
Can Lecanemab Revolutionize Alzheimer's Disease Treatment?
Alzheimer's disease (AD) poses a significant challenge worldwide, affecting millions of individuals and their families. However, a breakthrough may be...
2024-01-10 17:07 -
Study Finds Semaglutide Lower Suicide Ideation Risk Compared to Other Diabetes and Obesity Medicatio...
According to a new federally-funded study by the National Institutes of Health, the drugs semaglutide, commonly used to treat diabetes and obesity, ha...
2024-01-10 16:43 -
Is Metagenomi's IPO a Risky Bet in a Cooling Gene-Editing Market?
Metagenomi, an in vivo gene-editing company, has recently filed for an initial public offering (IPO) in the United States under the tick-symbol MGX.
2024-01-09 18:38 -
Is Now the Perfect Time to Invest in Biotech? The Rise of Goldman Sachs and TCGX Funds Signals a Shi...
Major pharmaceutical companies are ramping up mergers and acquisitions, while primary-market funds are also gearing up for action.
2024-01-09 18:35
Hot News
- SABIC Shuts Down 865,000-Ton U... Jul 02, 2025
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Sally Beauty Acquires Flair Ha... Jul 07, 2025
- The Truth Behind the US-China ... Jun 30, 2025
Related Products
Related Producers
